https://doi.org/10.1186/s12955-020-01549-z
H
Haifeng Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
109
Papers
715
Citations
14
h-index
17
i10-index
Haifeng Li is an academic researcher from Qingdao University. The author has contributed to research in topics: Myasthenia Gravis and Thymoma & Peripheral Neuropathies and Disorders & Parkinson's Disease and Spinal Disorders. The author has an h-index of 14, co-authored 93 publications.
ORCID: 0000-0001-8541-279XPapers by this author
worksGender differences in quality of life among patients with myasthenia gravis in China
2020 · Health and Quality of Life Outcomes · 58 citations
Optimal Sequential Strategies for Antibody-Drug Conjugate in Metastatic Breast Cancer: Evaluating Efficacy and Cross-Resistance
2024 · The Oncologist · 32 citations
https://doi.org/10.1093/oncolo/oyae055
Prognostic role of CD44 expression in osteosarcoma: evidence from six studies
2014 · Diagnostic Pathology · 15 citations
https://doi.org/10.1186/1746-1596-9-140
Potential biomarkers of spinal dural arteriovenous fistula: C4BPA and C1QA
2022 · Journal of Neuroinflammation · 12 citations
https://doi.org/10.1186/s12974-022-02522-x
Safety of inactivated SARS-CoV-2 vaccines in myasthenia gravis: A survey-based study
2022 · Frontiers in Immunology · 11 citations
https://doi.org/10.3389/fimmu.2022.923017
Prognostic value of the preoperative prognostic nutritional and systemic immunoinflammatory indexes in patients with colorectal cancer
2025 · BMC Cancer · 7 citations
https://doi.org/10.1186/s12885-025-13828-3
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat